This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: National Institute of Health and Medical Research, Université Paris Descartes, Université Paris Diderot-Paris 7. Active years: 2019.
Company Filing History:
1 out of 1,853 
1 out of 132 
1 out of 111 
Years Active: 2019
Title: Nimesh Gupta: Innovator in Mucosal Vaccination
Introduction
Nimesh Gupta is a prominent inventor based in Paris, France. He has made significant contributions to the field of immunology, particularly in the area of mucosal vaccination. His innovative approaches aim to enhance immune tolerance, which is crucial for various therapeutic applications.
Latest Patents
Nimesh Gupta holds a patent titled "Methods and pharmaceutical compositions for inducing immune tolerance by mucosal vaccination with Fc-coupled antigens." This invention relates to methods and pharmaceutical compositions designed to induce immune tolerance through mucosal vaccination. Specifically, it involves a method for inducing tolerance to a specific antigen in a subject by administering a therapeutically effective amount of a recombinant chimeric construct that includes a FcRn targeting moiety and an antigen-containing moiety. He has 1 patent to his name.
Career Highlights
Throughout his career, Nimesh Gupta has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université Paris Descartes. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Nimesh Gupta has collaborated with notable professionals in his field, including Roberto Mallone and Slobodan Culina. These collaborations have further enriched his research and innovation efforts.
Conclusion
Nimesh Gupta is a key figure in the development of mucosal vaccination techniques aimed at inducing immune tolerance. His contributions to the field are significant and continue to influence future research and applications in immunology.